Hard to pick the bottom on this one. Selling doesn’t seem to be over. Watching closely for a good entry point.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025